Latest Research, Industry, Medical and Scientific News
Urinary symptoms are frequent in patients with systemic sclerosis (SSc), especially in patients with limited cutaneous SSc, which have a 2.2 times higher risk of developing urinary symptoms than other SSc patients, and in patients who are positive for anti-centromere antibodies, who have a 2.8 times increased risk. Findings from the European multicenter study, “The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study,” appeared in a recent issue of the journal Rheumatology. The study (NCT01971294) enrolled a total of 334 patients diagnosed with systemic sclerosis from five centers in France, Italy, and Switzerland. All patients responded to questionnaires to assess urinary incontinence and its impact on their quality of life. Read more.
Source: Scleroderma News, October 10, 2017
In the November 2017 issue of Diseases of the Colon and Rectum, Dr. Charlène Brochard and her colleagues from a spina bifida referral center in Rennes, France, report on the frequency of intestinal problems in 26- to 45-year-old patients with spina bifida. The multidisciplinary study included clinical data obtained over a 9-year period on nearly 400 spina bifida patients, emphasizing the association of obesity with fecal incontinence and bowel dysfunction. Read more.
Source: News-Medical. net, October 9, 2017
Continence NZ is marking 25 years of providing support to the more than 1.1 million New Zealanders who live with bladder and bowel incontinence, by reminding affected Kiwis they don’t have to be embarrassed or suffer in silence. September 24-October 1 is Continence NZ’s Awareness Week. Incredibly, bladder and/or bowel control problems affect more than 1.1 million New Zealanders over the age of 15, including 25 percent of younger women, 34 percent of older women and 22 percent of older men. The impact on the physical and emotional health of people with incontinence issues can be significant and devastating, and is sadly often underestimated. Living with incontinence can feel humiliating, but Continence NZ is here to help. Read more.
Source: Scoop, September 29, 2017
Women in Uganda suffering from obstetric fistula just received a million reasons to be hopeful. Support from the Uganda Fistula Fund for TERREWODE, as well as the Hamlin International Partners in Australia and the United States, has raised over $1.6 million for TERREWODE, a non-governmental organization in East Uganda, which implements a community outreach program to provide surgical treatment and holistic education and empowerment for women with obstetric fistula. The funds will be used to build a specialized women’s hospital including a 30-bed fistula surgical block and a 30-bed social reintegration block in Soroti, Uganda, modeled after the renowned Hamlin Fistula Hospital in Ethiopia. Read more.
Source: Life Pulse Health, September 28, 2017
Urogyn B.V. and Leader Biomedical announce the first patient treated in Malaysia with Urolastic™– an innovative Urinary Stress Incontinence product that is exclusively offered by Leader Biomedical in India and APAC. We are excited to announce that we have successfully introduced Urolastic™ in Malaysia and treated a female patient suffering from severe Stress Urinary Incontinence (SUI). The patient suffered from the condition, as a result of birth deficiencies and was diagnosed with a short, yet very wide urethra. After previously undergoing a procedure using a bulking agent, the patient went down from using eight pads a day, to five pads a day. Treatment with Urolastic™ earlier this month by Dr. Warren Lo Hwa Loon at Pantai Hospital Kuala Lumpur has improved the patient’s condition, as a result of which she now only uses one pad a day, thus significantly improving her quality of life. Stress Urinary Incontinence is a disease affecting over 200 million people worldwide. Traditionally, SUI is treated with either a sling or injection of a bulking agent, where a sling procedure is an invasive procedure for the patient and the traditional bulking agents are expensive, as they are only effective for a short period and need to be repeated regularly. Read more.
Source: OpenPR, September 26, 2017
Essity, a leading global hygiene and health company, and Microsoft will partner to leverage the power of big data and cloud computing to further enhance Essity’s market-leading hygiene and health products and solutions around the world. Essity will implement Microsoft’s Azure cloud-based computing platform. Azure is a collection of integrated cloud services used to build, deploy and manage applications through Microsoft’s global network of data centers. Essity, which develops, produces and sells many of the world’s best-known hygiene and health products, including the global leading Tork and TENA brands, began to leverage big data to deliver smart solutions that help to improve the lives of people around the world four years ago, when it took an Internet of Things (IoT) approach to incontinence care for nursing home residents. Essity’s TENA Identifi was the first incontinence care product designed to electronically track a patient’s voiding patterns. The data is graphically converted into actionable, evidence-based reports to help nursing home staff optimize individualized continence care by ensuring that the right products are being used and that toilet routines are optimized, enhancing quality of life for nursing home residents. Read more.
Source: PRNewswire, September 20, 2017